Antiplatelet Medicines After Aneurysm Coiling: Why Stopping Them Is a Specialist Decision

The letter from the dental practice looks harmless. A routine extraction, it says, and a line near the bottom: please tell us if you take any blood thinners. The person reading it had a brain aneurysm coiled some months ago, feels completely well, and now has a small, uneasy question. Does one morning tablet really matter that much?

Questions about antiplatelet after aneurysm coiling tend to arrive like this, at the kitchen table rather than in the clinic. A surgeon wants a pre-operative pause. A pharmacist raises an eyebrow at an over-the-counter painkiller. A relative insists that aspirin thins the blood and the brain is the last place anyone wants thin blood.

The honest answer is that these medicines are doing a very specific job, that the job has a timeline, and that the only people who can see the whole picture are the team who looked at the angiogram and chose the device. This article explains why.

Antiplatelet after aneurysm coiling: what the medicine actually does in your blood

Platelets are tiny cell fragments that circulate in the blood and rush to plug any surface that looks like an injury. That instinct saves lives when you cut a finger. It becomes a liability when the surface in question is a metal mesh sitting inside a brain artery.

An antiplatelet medicine is a drug that makes platelets less sticky, so they are slower to clump on a damaged or foreign surface. Aspirin does this by permanently blocking an enzyme (cyclooxygenase-1) inside each platelet, so that platelet can no longer make thromboxane, one of its main clumping signals. Because the block is permanent, the effect on a given platelet lasts for that platelet’s lifetime, and clotting only returns to normal as the bone marrow releases a fresh supply (MedlinePlus). Clopidogrel, and newer relatives in the same P2Y12 inhibitor class such as prasugrel and ticagrelor, work on a different switch: they block the receptor that responds to ADP, another clumping signal (MedlinePlus).

Two things follow from this. First, aspirin and clopidogrel are not interchangeable; they shut different doors, which is why they are sometimes used together. Second, antiplatelets are not the same as anticoagulants. Anticoagulants such as warfarin or the direct oral anticoagulants act on the clotting proteins in plasma rather than on platelets, and are prescribed for different reasons, typically atrial fibrillation or a vein clot. People often lump all of them together as blood thinners, and that shorthand causes real confusion when another clinician asks what you take.

Why does any of this matter after coiling? Coils themselves sit inside the aneurysm sac, where a clot is exactly what the operator wants. The concern begins when a stent or flow diverter is added in the parent artery. Blood recognizes bare metal as damage. Until the artery’s own lining has grown over the struts, platelets will keep trying to build a clot there, and a clot in a brain artery is a stroke in the making. The medicine buys the artery time to heal over the device.

Why some coiled aneurysms need antiplatelets and others do not

Endovascular coiling means threading a fine catheter from an artery in the groin or wrist up into the brain, then packing the aneurysm with soft platinum coils until blood can no longer flow into it (NHS). Over the following weeks, the aneurysm fills with organized clot and scar, and the pressure on its fragile wall drops.

If the aneurysm has a narrow neck, the coils stay put on their own. Nothing is left in the main artery except a healed puncture far away in the groin. Many people in this situation are not asked to take any long-term antiplatelet medicine, although some teams use a short course around the procedure, and anyone with another reason to take one, such as a coronary stent, continues it (Mayo Clinic).

Wide-necked aneurysms are a different engineering problem. Coils dropped into a wide-mouthed sac tend to herniate back into the artery. Operators have three ways to hold them in place:

• A balloon, inflated briefly across the neck while coils are placed and then withdrawn. Nothing permanent is left behind.
• A stent, a permanent cylindrical mesh placed across the neck that acts as a scaffold for the coils.
• A flow diverter, a much denser mesh tube placed across the neck, often without coils, which redirects blood along the artery so the aneurysm slowly clots off from inside.

Permanent metal means platelets, and platelets mean antiplatelet medicine. That single fact explains most of the variation patients notice when they compare notes.

Rupture changes the calculation again. When an aneurysm has already bled into the space around the brain (a subarachnoid hemorrhage), antiplatelets complicate things: the person may need a drain to relieve pressure, and bleeding risk is already high. The AHA/ASA guideline on aneurysmal subarachnoid hemorrhage reflects this tension, and in practice teams often favor coil-only or balloon-assisted approaches after a rupture so that antiplatelets can be avoided or minimized, saving stents and flow diverters for planned treatment of unruptured aneurysms where the medicine can be started safely in advance (AHA/ASA).

Is aspirin recommended after aneurysm coiling?

Not universally, and that is the honest place to start. There is no guideline that tells every person who has had an aneurysm coiled to take aspirin for life. What exists is a set of device-specific habits, grounded more in observational experience and in cardiology than in large randomized trials of brain aneurysm patients.

When coils alone were used, aspirin is optional in the eyes of most teams. Some prescribe a short course around the procedure to reduce the chance of small clots forming on the coil surface where it meets the artery; others do not. The AHA/ASA guidance on unruptured aneurysms does not mandate antiplatelet treatment after coil-only procedures, and the decision usually rests on how much coil is visible at the neck and whether the person has other vascular reasons to take it (Mayo Clinic).

When a stent or flow diverter was placed, aspirin is almost always one half of the plan. It is typically paired with a P2Y12 inhibitor for a defined period, and it is frequently the medicine that continues longest after the second drug is stopped, sometimes indefinitely, because a flow diverter is a permanent implant with a large metal surface area (MedlinePlus; AHA/ASA).

Two cautions deserve a plain statement. Aspirin bought over the counter for aches is the same molecule, but taking extra on top of a prescribed regimen adds bleeding risk without adding protection. The reverse is also true: nobody should start aspirin after coiling on their own initiative because a relative or a website suggested it. If the team did not prescribe it, there is a reason, and that reason may be a drain, a planned operation, a stomach ulcer, or simply that no device was used.

The question people really mean is usually: will I be worse off without it? For a coil-only aneurysm, the evidence does not show a clear penalty. For a stent or flow diverter, the available evidence consistently points the other way.

Dual antiplatelet therapy with a flow diverter or stent: what the two-drug phase is for

Dual antiplatelet therapy, usually shortened to DAPT, means taking two antiplatelet medicines at once, almost always aspirin plus a P2Y12 inhibitor such as clopidogrel. The logic is simple: platelets have more than one way of being told to clump, and blocking two signals suppresses clot formation on a device far more reliably than blocking one.

The two-drug phase is built around a biological event the person cannot feel: endothelialization. Endothelium is the smooth single-cell lining of every blood vessel. After a stent or flow diverter is placed, this lining slowly grows over the struts until the metal is no longer in contact with flowing blood. While the struts are bare, the clot risk is highest, so both drugs are taken. Once the device is covered, one drug is usually stopped and the other continued.

Flow diverters sit at the demanding end of this spectrum. Their mesh is much denser than a conventional stent, and the aneurysm behind them closes gradually, over months rather than minutes, as the redirected flow lets clot organize inside the sac. Both features argue for a longer dual phase, and most teams plan accordingly.

What the evidence actually shows is worth saying plainly. The duration of DAPT after intracranial stents and flow diverters has never been settled by a large randomized trial. Protocols vary between centers and have largely been adapted from coronary stent practice, where the evidence base is stronger (AHA). This is not a scandal; it is the state of a young field. It does mean that two people with similar aneurysms may be given different timelines, and both may be reasonable.

Clopidogrel adds a wrinkle of its own. It is a prodrug, meaning the liver must convert it into its active form, and common genetic variants in the enzyme that does this (CYP2C19) make some people poor converters (MedlinePlus). Some teams measure platelet function or test for these variants before a flow diverter is placed and switch to a different P2Y12 inhibitor if the response is weak. Whether that testing improves outcomes remains an open research question, so practice differs.

Who usually stays on an antiplatelet after aneurysm coiling, and who is asked to wait

The clearest group is anyone with a permanent device in the parent artery. A stent-assisted coil or a flow diverter puts a person firmly in the stays-on category for as long as the team specifies, and often for a long time on a single agent afterward. The second clear group is anyone who already took an antiplatelet for another reason before the aneurysm was found: a coronary stent, a prior ischemic stroke, peripheral artery disease. Coiling does not usually remove that indication, though the team may adjust what is taken around the procedure (American Heart Association).

At the other end are people treated with coils alone or with a balloon-assisted technique, who have no other vascular reason for an antiplatelet. Many of them leave with no long-term antiplatelet at all, or a brief course that ends on a set date. For them, the sense that they should be on something because a neighbor is can be gently corrected.

Then there are those asked to wait, and waiting means different things in different situations:

• After a rupture, a team may defer stent-based treatment entirely, choosing coil-only now and planning a second, stent-assisted procedure later once the brain has recovered and antiplatelets can be started safely (AHA/ASA).
• Before a planned flow diverter, people are usually asked to start the medicines days ahead so that platelets are already suppressed when the device goes in. Here waiting applies to the procedure, not the medicine.
• People with an active stomach ulcer, a recent major bleed, a known aspirin allergy or a scheduled operation may have their regimen adjusted or their device choice changed before anything is prescribed.

What unites all three categories is that the sorting is done by the team with the angiogram in front of them. The images show how much metal sits in the artery, how wide the neck was, whether any coil loops protrude, and how the artery is healing on follow-up. None of that is visible from the outside, which is why the same question from two patients can get two different answers.

Coil-only, stent-assisted or flow diverter: how the antiplatelet plan typically differs

A single table captures most of the variation, with the caveat that it describes common patterns rather than rules. Durations are deliberately left as descriptions, because no guideline fixes them and the team’s judgment about the individual artery always takes precedence (AHA/ASA; Mayo Clinic).

Technique	What stays in the parent artery	Typical antiplatelet approach	Why
Coil-only	Nothing permanent	Often none long term; some teams give a short course around the procedure	Clot inside the aneurysm sac is the goal; little metal faces flowing blood
Balloon-assisted coiling	Nothing permanent; balloon is withdrawn	Similar to coil-only	Scaffold is temporary
Stent-assisted coiling	Permanent mesh stent	Dual therapy for a defined period, then a single agent for longer	Bare struts attract platelets until the artery lining covers them
Flow diverter	Permanent dense mesh tube	Dual therapy, usually started before the procedure and continued longer than for a conventional stent, then a single agent, sometimes indefinitely	Denser metal and slower aneurysm closure extend the vulnerable period
Any technique after a rupture	Varies	Teams often avoid permanent devices so antiplatelets can be minimized	Recent bleed and possible drains raise bleeding risk

A few observations about the table. The move from the second row to the third is where the medicine becomes non-negotiable, and it is also the move patients are least likely to be told about in detail, because it happens during a procedure they are sedated for. Asking which row you are in is one of the most useful questions anyone can bring to a follow-up appointment.

The last row explains a pattern many families notice on neurosurgical wards: the person who collapsed with a hemorrhage and was coiled as an emergency may take no antiplatelet at all, while the person who came in for a planned flow diverter after a scan found an unruptured aneurysm takes two. The difference is not that one aneurysm was more dangerous; it is that one treatment left metal in the artery and the other did not.

How long does it take to recover from brain coiling, and where do the medicines fit in?

For a planned procedure on an unruptured aneurysm, the physical recovery is often shorter than people expect. The entry wound is a small puncture in the groin or wrist. Most people are up and walking within a day, and the NHS describes a hospital stay of a few days for a planned procedure, with a return to normal activities over the following weeks as energy returns (NHS). Headache, tiredness and tenderness at the puncture site are common in the first week or two and usually fade. Driving and heavy lifting are typically restricted for a period the team specifies.

After a rupture, the timeline is measured in weeks rather than days. The AHA/ASA guideline describes a window of roughly the first two weeks after a subarachnoid hemorrhage during which arteries can narrow (vasospasm) and the brain is at risk of delayed injury, so people are monitored closely in hospital through that period and may need rehabilitation afterward (AHA/ASA). Recovery from the bleed, not from the coiling, is what dominates.

Medicines thread through both timelines in a way that is easy to misjudge. The vulnerable period for a stent or flow diverter does not end when the groin heals or when the headache lifts. It ends when the artery lining has grown over the metal, which happens on a schedule of months and cannot be felt. A person can be back at work, exercising and symptom-free while still inside the window where a missed stretch of antiplatelet medicine carries real risk.

Follow-up imaging is the other anchor. The team will usually arrange an angiogram or MR angiogram at intervals after the procedure to check that the aneurysm has stayed closed and that the artery is healing around any device (Mayo Clinic). Changes to the antiplatelet plan are often tied to what those images show, so a scan appointment and a medication review tend to arrive together. Keeping both is part of the treatment, not an optional extra.

Stopping clopidogrel after coiling: why a short break is not a small thing

Here is the part that surprises people. Clopidogrel does not feel like a powerful medicine. There is no sensation of taking it and none of stopping it. That silence is precisely the problem, because the consequences of a gap are invisible until they are catastrophic.

The feared event is device thrombosis: a clot forming on the stent or flow diverter and either blocking the artery or breaking off and travelling downstream. In the brain, that is an ischemic stroke. Cardiology has studied this risk for decades in coronary stents, and premature interruption of dual antiplatelet therapy stands out as one of the strongest predictors of stent thrombosis in that literature (American Heart Association). Neurointerventional teams have borrowed that lesson, with reason: the brain tolerates lost blood flow even less forgivingly than the heart.

The risk is not evenly spread. It is highest in the early months while struts are bare, and it falls as the lining covers the device. This is why a team may be relaxed about a pause two years after a conventional stent and firm about not pausing at all a few weeks after a flow diverter. The same request gets different answers because the artery is at a different stage.

People stop clopidogrel for understandable reasons. Bruises bloom on the forearms. A nosebleed takes longer to settle. Another clinician says it is fine to pause for a procedure. A prescription runs out on a weekend. Each of these is a reason to call the neurointerventional team, not a reason to act alone. Bruising and minor bleeding are expected side effects that the team weighs against clot risk every day; they are rarely a reason to stop, and if the bleeding is more than minor, the team may adjust the plan rather than abandon it (MedlinePlus).

Missed doses deserve the same approach. Rather than guessing whether to take a missed one later, ask the team or the pharmacist who dispensed it what they want you to do. The instruction is simple to give and specific to the medicine, and guessing wrong in either direction has costs.

Dental work, scopes and surgery: planning around antiplatelet medicine

Most people on antiplatelets after coiling will, sooner or later, need something else done. A tooth out. A colonoscopy. A cataract. A knee. Each brings a clinician who, quite properly, wants to know about bleeding risk, and who may suggest a pause without knowing why the medicine was started.

The first thing worth knowing is that many minor procedures can go ahead without stopping antiplatelets at all. Routine dental extractions and fillings are commonly performed on people taking aspirin or clopidogrel, with local measures to control bleeding, and the NHS advises people on these medicines to tell the dentist rather than stop (NHS). The same is true of many skin procedures and some endoscopies without biopsy.

The second is that antiplatelets cannot be bridged the way anticoagulants sometimes are. With warfarin, a short-acting injectable anticoagulant can cover a gap. There is no equivalent routine bridge for aspirin or clopidogrel, so a pause is a genuine gap in protection, which is exactly why the device team needs to be in the conversation.

The third is timing. For a truly elective operation, the safest plan is often to wait until the device has passed through its most vulnerable phase, when the team may be comfortable with a brief, planned interruption of one agent while continuing the other. For an urgent operation, the surgeon and the neurointerventional team will weigh bleeding against clotting together, and may decide to operate on the medicine. These are specialist conversations between specialists; a patient’s job is to make sure both sides are talking.

Practical steps that help:

• Carry a card or phone note stating the device type, the date it was placed and the names of the antiplatelet medicines.
• Give the name and contact details of the neurointerventional team to any clinician proposing a procedure.
• Ask that any pause be confirmed by that team, in writing if possible, before it begins.

None of this is about mistrusting the dentist or the surgeon. It is about recognizing that the person who placed a flow diverter knows something about your artery that nobody else can know.

Can an aneurysm rupture after coiling?

Rarely, yes. Coiling greatly reduces the chance that an aneurysm will bleed, but it is not a guarantee of permanent closure, and honesty about that is more useful than reassurance.

The best long-term evidence comes from the International Subarachnoid Aneurysm Trial (ISAT), which randomized people with ruptured aneurysms suitable for either treatment to coiling or to surgical clipping. At one year, 23.7% of those coiled were dead or dependent compared with 30.6% of those clipped, a result that reshaped practice worldwide (ISAT, PubMed). The same trial also recorded that rebleeding from the treated aneurysm, while uncommon in both groups, occurred slightly more often after coiling, and that coiled aneurysms more often needed a second procedure (ISAT, PubMed). The trade-off was judged worthwhile, and it still is, but the small residual risk is why follow-up imaging exists.

Two mechanisms account for most late problems. Coil compaction is the settling of coils under the pressure of pulsing blood, which can reopen a channel at the neck. Aneurysm regrowth is the enlargement of the sac or neck around the coils. Large and wide-necked aneurysms are more prone to both, and these are the same aneurysms for which stents and flow diverters are chosen (Mayo Clinic). Retreatment, when needed, is usually another endovascular procedure.

Now the question beneath the question: does the antiplatelet medicine make a rupture more likely? No. Aspirin and clopidogrel act on platelets, not on the aneurysm wall, and there is no evidence that they cause a coiled aneurysm to reopen or burst. What they would do, if a rupture happened, is make the resulting bleed harder to control. That is a real consideration, and it is part of why teams try to avoid permanent devices after a recent hemorrhage. It is not a reason to stop a medicine that is protecting a stent in a person whose aneurysm has been closed.

The modifiable factors that matter most for rupture risk are the familiar ones: smoking and uncontrolled blood pressure (NHS). Those are within reach of the person reading this in a way that coil compaction is not.

What people often get wrong about antiplatelets and coiling

Most misunderstandings here come from reasonable instincts applied to the wrong situation. A few of the commonest, with the correction the evidence supports.

Blood thinners and brain aneurysms do not mix. This is true for the fragile wall of an untreated or freshly ruptured aneurysm, and false for a stent or flow diverter in a healed artery. The same phrase describes two opposite risks. Once an aneurysm is excluded from the circulation and a device sits in the parent vessel, the dominant danger is clot, not bleed (AHA/ASA).

Aspirin is mild, so stopping it is no big deal. Aspirin’s permanent effect on each platelet is exactly what makes it useful on a device, and its absence is felt by the artery even when it is not felt by the person (MedlinePlus).

I feel fine, so the artery must have healed. Endothelial coverage of a device has no symptoms. Feeling well tells you nothing about whether the struts are still bare.

Ibuprofen is fine because it is not aspirin. Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and naproxen add to bleeding risk and can interfere with aspirin’s effect on platelets. People on antiplatelets are generally advised to check with the team before using them regularly (MedlinePlus).

Supplements do not count as medicines. Fish oil, ginkgo, garlic extract and high-dose vitamin E all have reported effects on bleeding, and the NIH Office of Dietary Supplements advises anyone on antiplatelet or anticoagulant medicines to discuss supplements with their clinician. The team cannot weigh what it does not know about.

Once the coils are in, I am done. Coiling is a treatment with follow-up built in. The scans, the medication reviews and the blood pressure checks are part of it (Mayo Clinic).

My cardiologist, or my GP, can decide about the clopidogrel. They can advise, and they should be involved. But the person who knows what metal is in your brain artery and how it looked on the last angiogram is the one who should have the final word.

What not to do after brain aneurysm coiling

Lists of prohibitions can feel infantilizing, so it helps to understand the reasoning behind each one. These are the actions that most often cause avoidable trouble, grouped by what they put at risk.

Do not stop, skip or stretch out the antiplatelet medicine without the device team’s agreement. This is the single most consequential item, for the reasons set out above. If a pause is proposed by anyone, route the question to the team before acting.

Do not add aspirin, NSAIDs or bleeding-related supplements on your own. Extra platelet inhibition adds bleeding risk without adding device protection, and NSAIDs can blunt aspirin’s effect (MedlinePlus).

Do not smoke. Smoking is among the strongest modifiable risk factors for aneurysm formation, growth and rupture, and it also damages the arterial lining that needs to grow over a device (NHS). Stopping after coiling is one of the few things that protects both the treated aneurysm and the rest of the brain’s arteries.

Do not let blood pressure go unchecked. High pressure strains any residual aneurysm neck and raises the risk of coil compaction and new aneurysms (Mayo Clinic). Home monitoring and keeping primary care appointments matter more than any single lifestyle rule.

Do not ignore the puncture site. Expanding swelling, a hard lump, new pain, numbness or a cold, pale limb below the groin or wrist entry point should be reported the same day.

Do not resume driving, heavy lifting or contact sport before the team clears it. The reasons are partly about the puncture site in the first days and partly about seizure risk and recovery after a hemorrhage; the team sets the timeline for your situation (NHS).

Do not assume other clinicians know your history. Hospital records do not always travel. Say the words stent or flow diverter out loud at every new encounter.

None of these restrictions are permanent in the way the device is. Most lift on a schedule the team can describe, and asking for that schedule is reasonable.

Questions to ask your care team

Appointments after coiling are often short, and the questions that matter most are easy to forget in the moment. Writing them down beforehand changes the conversation. These are the ones that tend to produce the most useful answers.

• Which technique was used: coils alone, balloon-assisted, stent-assisted or a flow diverter? Is there a permanent device in the artery?
• Which antiplatelet medicines am I taking, and which one is protecting the device?
• How long is the two-drug phase expected to last, what will decide when it ends, and which medicine continues afterward?
• If I need an operation, a dental extraction or an endoscopy, who should the other clinician contact, and how far in advance?
• What should I do if I miss a dose, run out, or vomit shortly after taking one?
• Which over-the-counter painkillers are acceptable for headaches, and which should I avoid?
• Are there supplements or herbal products I should mention or stop?
• What bleeding is expected and tolerable, and what level of bleeding should make me call?
• When is my next follow-up scan, and will my medication be reviewed at the same visit?
• Is there a card, letter or record I should carry stating the device and the medicines?
• What are my personal targets for blood pressure, and who monitors them?
• Is there anything about my genetics or platelet testing that influenced the choice of medicine?

Two of these deserve a special mention. The first question, about which technique was used, is the one that unlocks everything else; people are often surprised to discover they are not sure. The question about who other clinicians should contact is the one that prevents the kitchen-table dilemma this article began with. A named contact point, written down, turns a lonely decision into a routine phone call.

It is also entirely reasonable to ask the team to explain the uncertainty. Where the evidence is thin, as it is for the exact duration of dual therapy, a good clinician will say so and explain how they chose. That honesty is a sign of a careful team, not a hesitant one.

When to call your doctor

Most days after coiling are uneventful, and most of the symptoms people worry about, such as mild headache or forearm bruising, are expected. A short list of signs should bypass worry and go straight to a phone call or emergency services, because they may point to a clot on the device, a bleed, or a problem at the puncture site (Mayo Clinic; NHS).

Call emergency services immediately for:

• Sudden weakness or numbness of the face, arm or leg, especially on one side
• Sudden difficulty speaking, understanding speech, or confusion
• Sudden loss or blurring of vision in one or both eyes
• Sudden severe headache unlike any before, particularly with a stiff neck, vomiting or sensitivity to light
• A seizure, or collapse and loss of consciousness
• Vomiting blood, or passing black, tarry or bloody stools

The first three are the classic signs of stroke, and in someone with a stent or flow diverter they are treated as device thrombosis until proven otherwise. Time lost waiting to see if they pass is time the brain does not get back.

Contact the treating team or your doctor the same day for:

• Swelling, a growing lump, severe pain, or bleeding at the groin or wrist puncture site that does not stop with firm pressure
• A cold, pale, numb or painful limb below the puncture site
• Nosebleeds or gum bleeding that are heavy or will not stop
• Bruising that is extensive or appears without any knock
• Blood in the urine
• A rash, itching, swelling of the face or lips, or wheeze after a new medicine
• Any missed doses, a run-out, or another clinician asking you to pause the medicine

The last item is not a medical emergency, but it is the call that prevents one. Questions about pausing, switching or restarting antiplatelet medicine after aneurysm coiling belong with the neurointerventional team, and most teams would far rather hear from a patient about a dental appointment than hear about a stroke afterward. Every decision about these medicines sits with the clinicians who placed the device and who can see how the artery is healing.

Frequently asked questions

Is aspirin recommended after aneurysm coiling?

Only in certain situations. When coils alone were used, many teams prescribe no long-term aspirin or a brief course around the procedure. When a stent or flow diverter was placed, aspirin is usually part of a two-drug plan and is often the medicine continued longest. Nobody should start or stop aspirin after coiling without the device team’s agreement, because the right answer depends on what was left in the artery.

Why do I need two antiplatelet medicines after a flow diverter when a friend coiled last year takes none?

Because your treatments left different things behind. A flow diverter is a dense permanent mesh in the main artery that platelets will clot onto until the vessel lining covers it, so two drugs acting on different platelet pathways are used during that healing phase. Coils alone sit inside the aneurysm sac and leave little metal facing flowing blood, so many people need no antiplatelet at all.

Can I pause stopping clopidogrel after coiling just for a few days before a tooth extraction?

Not without checking with the neurointerventional team first. Routine extractions are commonly performed on people taking clopidogrel and aspirin, using local measures to control bleeding, so a pause is often unnecessary. If a pause is genuinely needed, the device team will decide whether the artery has healed enough for it to be safe. A gap in protection early after a stent or flow diverter can allow a clot to form on the device.

Can an aneurysm rupture after coiling?

Rarely, yes. Coiling greatly lowers the risk of bleeding, but coils can compact and aneurysms can regrow, especially large or wide-necked ones, which is why follow-up imaging is arranged. In the ISAT trial, rebleeding after coiling was uncommon but slightly more frequent than after clipping, and retreatment was needed more often. Antiplatelet medicines do not cause a coiled aneurysm to rupture; they act on platelets, not on the aneurysm wall.

How long does it take to recover from brain coiling after an aneurysm?

It depends mainly on whether the aneurysm had bled. After a planned procedure for an unruptured aneurysm, people are usually walking within a day, stay in hospital for a few days, and recover over weeks as tiredness and headache fade. After a rupture, the first two weeks or so are spent under close monitoring for delayed brain injury, and recovery and rehabilitation can take months. Antiplatelet timelines run on a separate, longer clock tied to device healing.

What not to do after brain aneurysm coiling?

Do not stop or skip prescribed antiplatelet medicine without the device team’s agreement, do not add over-the-counter aspirin, NSAIDs or bleeding-related supplements on your own, and do not smoke. Keep blood pressure checked, report any changes at the puncture site, and wait for clearance before driving, heavy lifting or contact sport. Tell every new clinician about any stent or flow diverter, since records do not always follow you.

Does dual antiplatelet therapy with a flow diverter last forever?

Usually not in its two-drug form. The dual phase covers the months while the artery lining grows over the mesh, after which one medicine is typically stopped and the other, often aspirin, continues for longer and sometimes indefinitely because the implant is permanent. No large trial has fixed the exact duration, so centers differ. The team decides based on follow-up imaging and your individual bleeding and clotting risks.

Why does my antiplatelet plan differ from someone treated at another center?

Because the evidence does not settle the details. The duration of dual therapy after intracranial stents and flow diverters has largely been adapted from coronary stent practice rather than defined by brain-specific randomized trials, so experienced teams make reasonable but different choices. Device type, aneurysm size, how the artery looks on follow-up scans and your personal bleeding risk all shape the plan. Different does not mean one team is wrong.

Can I take ibuprofen for headaches after coiling?

Check with your team before using it regularly. Ibuprofen and other NSAIDs add to bleeding risk when combined with antiplatelet medicines and can interfere with aspirin’s effect on platelets. Headaches are common in the weeks after coiling, and the team can advise which pain relief fits your regimen. A sudden severe headache unlike any before is different and needs emergency assessment rather than a painkiller.

Do supplements like fish oil or ginkgo matter if I take clopidogrel after coiling?

They can. Fish oil, ginkgo, garlic extract and high-dose vitamin E have all been reported to affect bleeding, and the NIH Office of Dietary Supplements advises people on antiplatelet or anticoagulant medicines to discuss any supplement with their clinician. The team cannot weigh a risk it does not know about, so bring a list of everything you take, including herbal products, to your follow-up appointments.

References

• NHS: Brain aneurysm, Treatment
• MedlinePlus: Clopidogrel
• MedlinePlus: Aspirin

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.